Treating Fairly Research Award

About this funding opportunity

Jump to Main Content American Society of Hematology Awards Early and Mid-Career Investigator Awards and Training Programs Treating Fairly Education Publications Agenda for Nematology Research Recommendations About Us Precision Medicine Genome Editing and Gene Therapy Immunologic Treatment Research Support and Funding Meetings Careers Treating Fairly Research Award

The ASH Treating Fairly Research Award program was established in response to concerns about recent shifts in federal funding priorities, which have reduced support for research focused on hematologic diseases and disorders that disproportionately affect specific communities. ASH has long recognized the importance of addressing these disparities and remains committed to advancing equitable and fair outcomes for all patients. Securing funding for research that supports this mission is essential. Join ASH to Help Bridge Funding Gaps

ASH increased its commitment to funding critical hematology research this year by $9 million to establish new awards and fund an additional 600+ awards to make up for the gaps in opportunity resulting from federal funding cuts, bringing ASH’s total investment to more than $20 million in 2025-2026. It’s going to take your help to sustain that momentum beyond this first year. Donate to the ASH Foundation to help protect the future of hematology research when it’s needed most.

Donate to Support Research Funding Key Information Program Benefits

The Treating Fairly Research Award provides $200,000 in funding, which may be used over a period of 1, 2, or 3 years depending on the recipient’s preference. It is available to researchers who hold a PhD, an MD/DO, or an MD/DO, PhD who are no longer eligible for the ASH AMFDP and ASH Scholar Awards.

See Additional Benefit Information Eligibility Requirements

Applicants must be ASH members serving as Principal Investigators at eligible institutions, be U.S., Mexico, or Canadian citizens (or visa/PR holders conducting research in the U.S., Mexico, or Canada), have no more than $500,000 in other resources, and meet all criteria by the application deadline. See Additional Eligibility Requirements Application Process and Required Materials

Applications must be submitted through the ASH online awards system and include all required forms, statements, budget details, biographical sketch, project proposal, ethical certification, and resource information. See Additional Information on Required Materials Evaluation and Selection

Award applications are assessed based on the scientific merit and qualifications of the applicant. To maintain programmatic balance, a maximum of two awards will be granted per medical school. Individuals selected to receive this award will be notified in March 2026 with the award commencing upon notification. See Evaluation Criteria Key Dates

Application Available September 15, 2025 Application Deadline January 5, 2026 Award Notification April 2026 Award Activation Upon Notification

Topic areas: Life Sciences and Health, Gender Equality and Diversity, Social Sciences and Humanities.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

Treating Fairly Research Award is administered by American Society of Hematology (ASH), listed via American Society of Hematology.